Chester County News and Community Website
West Pharmaceutical Services, Inc. (NYSE: WST), headquartered in Exton, PA, is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products.
EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) has announced its financial results for the fourth quarter and full-year 2024, highlighting a return to organic growth and setting optimistic guidance …
West Pharmaceutical Services Reports Strong Q4, Introduces 2025 Financial Guidance Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has approved a first-quarter 2025 dividend of $0.21 per share.
West Pharmaceutical Services Declares Q1 2025 Dividend Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) has introduced a new nested format for its Daikyo PLASCAP® Ready-to-Use Validated (RUV) closures, available in multiple configurations. This advancement, revealed at …
West Pharmaceutical Unveils New Nested Format for Daikyo PLASCAP RUV Closures Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) has announced the recent election of Janet Haugen to its Board of Directors. With her appointment, the board now consists of 12 …
Janet Haugen Joins West Pharmaceutical Services Board of Directors Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) has released its financial results for the third quarter of 2024, alongside an updated financial outlook for the year. The company …
West Pharmaceutical Services Reports Solid Third-Quarter 2024 Results and Raises Guidance Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) has been recognized with the prestigious Heart of Pharma Award at the 2024 CPHI Awards. This accolade, awarded during the opening night …
West Pharmaceutical Services Honored with Heart of Pharma Award for Cancer Partnership Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) reported its second-quarter 2024 financial results, revealing a significant drop in net sales and adjusted earnings per share (EPS). The company …
West Pharmaceutical Services Downscales 2024 Financial Outlook Amid Customer Destocking Challenges Read More